Lomustine Eureco-Pharma
As listed in the register: Lomustine Eureco-Pharma, capsules, hard 40 mg
40 mg · capsule, hard
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Lomustine
- Made by
- Eureco-Pharma B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Lomustine). It describes the substance, not this exact product.
Lomustine alkylates DNA and RNA.
As with other nitrosoureas, it may also inhibit several key enzymatic processes by carbamoylation of amino acids in proteins.
Following oral administration of radioactive lomustine at doses ranging from 30 mg/m 2 to 100 mg/m 2, approximately half of the radioactivity administered was excreted in the urine in the form of degradation products within 24 hours.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-02-12
Safety of the active substance
From the US prescribing label for the same active substance (Lomustine). It describes the substance, not this exact product.
WARNING: DELAYED MYELOSUPPRESSION and RISK OF OVERDOSAGE DELAYED MYELOSUPPRESSION Lomustine causes myelosuppression including fatal myelosuppression.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Details
| Made by | Eureco-Pharma B.V. |
|---|---|
| Active substance | Lomustine |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 40 mg |
| Form | capsule, hard |
| Classification | L01AD02 · Cancer treatments and immune-system medicines |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Lomustine Eureco-Pharma, capsules, hard 40 mg |
| RVG | 126969//07439 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.